Biden proposes Medicare, Medicaid coverage of obesity drugs

Contributing sentiments towards policy:

53% : Meanwhile, Trump's pick to run the Centers for Medicare and Medicaid Services, Mehmet Oz, has spoken positively about the drugs in the past.
46% : Medicare and Medicaid currently cover the cost of some obesity medication to treat certain diseases like diabetes and heart disease.
41% : The cost of rolling out such an expansion in coverage would be significant, and a bill authorizing Medicare to cover anti-obesity medication has been stalled in Congress for years.
28% : The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans.Millions of Americans suffer from obesity, which is considered a chronic disease that can lead to serious health consequences like cardiovascular disease, stroke and diabetes.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.